Header Logo

Connection

SANJAY MATHEW to Hallucinogens

Back to Details
This is a "connection" page, showing publications SANJAY MATHEW has written about Hallucinogens.
SANJAY MATHEW
Connection Strength
0.076
Hallucinogens
  1. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol. 2010 Feb; 13(1):71-82.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.